Advanced glycation end products inhibit the osteogenic differentiation potential of adipose‐derived stem cells by modulating Wnt/β‐catenin signalling pathway via DNA methylation

OBJECTIVES: Advanced glycation end products (AGEs) are considered a cause of diabetic osteoporosis. Although adipose‐derived stem cells (ASCs) are widely used in the research of bone regeneration, the mechanisms of the osteogenic differentiation of ASCs from diabetic osteoporosis model remain unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Wang, Lang, zhang, Maorui, Huang, Kui, Yao, Zhihao, Rao, Pengcheng, Cai, Xiaoxiao, Xiao, Jingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309593/
https://www.ncbi.nlm.nih.gov/pubmed/32468637
http://dx.doi.org/10.1111/cpr.12834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309593/
https://www.ncbi.nlm.nih.gov/pubmed/32468637
http://dx.doi.org/10.1111/cpr.12834

Ejemplares similares